Developmental origins of thymus-derived natural killer cells

Natural Killer Cells

Volumn , Issue , 2010, Pages 25-39

  Carlyle, James R ^a   Zúñiga Pflücker, Juan C ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884809300     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-370454-2.00002-8     Document Type: Chapter

References (94)

1. Aldemir H., Prod'homme V., Dumaurier M.J., Retiere C., Poupon G., Cazareth J., Bihl F., Braud V.M. Cutting edge: lectin-like transcript 1 is a ligand for the CD161 receptor. J Immunol 2005, 175:7791-7795.
2. Arase H., Saito T., Phillips J.H., Lanier L.L. Cutting edge: the mouse NK cell-associated antigen recognized by DX5 monoclonal antibody is CD49b (alpha 2 integrin, very late antigen-2). J Immunol 2001, 167:1141-1144.
3. Bell S.E., Zamoyska R. Identification of thymocyte precursors in murine fetal liver. Eur J Immunol 1991, 21:2931-2936.
4. Bennett I.M., Zatsepina O., Zamai L., Azzoni L., Mikheeva T., Perussia B. Definition of a natural killer NKR-P1A+/CD56-/CD16-functionally immature human NK cell subset that differentiates in vitro in the presence of interleukin 12. J Exp Med 1996, 184:1845-1856.
5. Bhandoola A., von Boehmer H., Petrie H.T., Zúñiga-Pflücker J.C. Commitment and developmental potential of extrathymic and intrathymic T cell precursors: plenty to choose from. Immunity 2007, 26:678-689.
6. Blom B., Res P., Noteboom E., Weijer K., Spits H. Prethymic CD34+ progenitors capable of developing into T cells are not committed to the T cell lineage. J Immunol 1997, 158:3571-3577.
7. Boos M.D., Yokota Y., Eberl G., Kee B.L. Mature natural killer cell and lymphoid tissue-inducing cell development requires Id2-mediated suppression of E protein activity. J Exp Med 2007, 204:1119-1130.
8. Boos M.D., Ramirez K., Kee B.L. Extrinsic and intrinsic regulation of early natural killer cell development. Immunol Res 2008, 40:193-207.
9. Burkett P.R., Koka R., Chien M., Chai S., Boone D.L., Ma A. Coordinate expression and trans presentation of interleukin (IL)-15Ralpha and IL-15 supports natural killer cell and memory CD8+ T cell homeostasis. J Exp Med 2004, 200:825-834.
10. Carlyle J.R., Zúñiga-Pflücker J.C. Lineage commitment and differentiation of T and natural killer lymphocytes in the fetal mouse. Immunol Rev 1998, 165:63-74.
11. Carlyle J.R., Zúñiga-Pflücker J.C. Regulation of NK1.1 expression during lineage commitment of progenitor thymocytes. J Immunol 1998, 161:6544-6551.
12. Carlyle J.R., Zúñiga-Pflücker J.C. Requirement for the thymus in alpha beta T lymphocyte lineage commitment. Immunity 1998, 9:187-197.
13. Carlyle J.R., Michie A.M., Furlonger C., Nakano T., Lenardo M.J., Paige C.J., Zúñiga-Pflücker J.C. Identification of a novel developmental stage marking lineage commitment of progenitor thymocytes. J Exp Med 1997, 186:173-182.
14. Carlyle J.R., Michie A.M., Cho S.K., Zúñiga-Pflücker J.C. Natural killer cell development and function precede alpha beta T cell differentiation in mouse fetal thymic ontogeny. J Immunol 1998, 160:744-753.
15. Carlyle J.R., Martin A., Mehra A., Attisano L., Tsui F.W., Zúñiga-Pflücker J.C. Mouse NKR-P1B, a novel NK1.1 antigen with inhibitory function. J Immunol 1999, 162:5917-5923.
16. Carlyle J.R., Jamieson A.M., Gasser S., Clingan C.S., Arase H., Raulet D.H. Missing self-recognition of Ocil/Clr-b by inhibitory NKR-P1 natural killer cell receptors. Proc Natl Acad Sci U S A 2004, 101:3527-3532.
17. Carlyle J.R., Mesci A., Ljutic B., Belanger S., Tai L.H., Rousselle E., Troke A.D., Proteau M.F., Makrigiannis A.P. Molecular and genetic basis for strain-dependent NK1.1 alloreactivity of mouse NK cells. J Immunol 2006, 176:7511-7524.
18. Carlyle J.R., Mesci A., Fine J.H., Chen P., Belanger S., Tai L.H., Makrigiannis A.P. Evolution of the Ly49 and Nkrp1 recognition systems. Semin Immunol 2008, 20:321-330.
19. Carotta S., Brady J., Wu L., Nutt S.L. Transient Notch signalling induces NK cell potential in Pax5-deficient pro-B cells. Eur J Immunol 2006, 36:3294-3304.
20. Cella, M., Fuchs, A., Vermi, W., Facchetti, F., Otero, K., Lennerz, J.K., Doherty, J.M., Mills, J.C. and Colonna, M. (2008). A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature.
21. Cupedo T., Crellin N.K., Papazian N., Rombouts E.J., Weijer K., Grogan J.L., Fibbe W.E., Cornelissen J.J., Spits H. Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC(+) CD127(+) natural killer-like cells. Nat Immunol 2009, 10:66-74.
22. Di Santo J.P., Vosshenrich C.A. Bone marrow versus thymic pathways of natural killer cell development. Immunol Rev 2006, 214:35-46.
23. Douagi I., Colucci F., Di Santo J.P., Cumano A. Identification of the earliest prethymic bipotent T/NK progenitor in murine fetal liver. Blood 2002, 99:463-471.
24. Douagi I., Vieira P., Cumano A. Lymphocyte commitment during embryonic development in the mouse. Semin Immunol 2002, 14:361-369.
25. Eberl G. Inducible lymphoid tissues in the adult gut: recapitulation of a fetal developmental pathway?. Nat Rev Immunol 2005, 5:413-420.
26. Fraser K.P., Gays F., Robinson J.H., van Beneden K., Leclercq G., Vance R.E., Raulet D.H., Brooks C.G. NK cells developing in vitro from fetal mouse progenitors express at least one member of the Ly49 family that is acquired in a time-dependent and stochastic manner independently of CD94 and NKG2. Eur J Immunol 2002, 32:868-878.
27. Grzywacz B., Kataria N., Sikora M., Oostendorp R.A., Dzierzak E.A., Blazar B.R., Miller J.S., Verneris M.R. Coordinated acquisition of inhibitory and activating receptors and functional properties by developing human natural killer cells. Blood 2006, 108:3824-3833.
28. Hattori N., Kawamoto H., Katsura Y. Isolation of the most immature population of murine fetal thymocytes that includes progenitors capable of generating T, B, and myeloid cells. J Exp Med 1996, 184:1901-1908.
29. Huntington N.D., Vosshenrich C.A., Di Santo J.P. Developmental pathways that generate natural-killer-cell diversity in mice and humans. Nat Rev Immunol 2007, 7:703-714.
30. Iizuka K., Naidenko O.V., Plougastel B.F., Fremont D.H., Yokoyama W.M. Genetically linked C-type lectin-related ligands for the NKRP1 family of natural killer cell receptors. Nat Immunol 2003, 4:801-807.
31. Ikawa T., Kawamoto H., Fujimoto S., Katsura Y. Commitment of common T/natural killer (NK) progenitors to unipotent T and NK progenitors in the murine fetal thymus revealed by a single progenitor assay. J Exp Med 1999, 190:1617-1626.
32. Jaleco A.C., Blom B., Res P., Weijer K., Lanier L.L., Phillips J.H., Spits H. Fetal liver contains committed NK progenitors, but is not a site for development of CD34+ cells into T cells. J Immunol 1997, 159:694-702.
33. Jamieson A.M., Diefenbach A., McMahon C.W., Xiong N., Carlyle J.R., Raulet D.H. The role of the NKG2D immunoreceptor in immune cell activation and natural killing. Immunity 2002, 17:19-29.
34. Kanamori Y., Ishimaru K., Nanno M., Maki K., Ikuta K., Nariuchi H., Ishikawa H. Identification of novel lymphoid tissues in murine intestinal mucosa where clusters of c-kit+ IL-7R+ Thy1+ lympho-hemopoietic progenitors develop. J Exp Med 1996, 184:1449-1459.
35. Kawamoto H., Ohmura K., Katsura Y. Presence of progenitors restricted to T, B, or myeloid lineage, but absence of multipotent stem cells in the murine fetal thymus. J Immunol 1998, 161:3799-3802.
36. Kim S., Iizuka K., Kang H.S., Dokun A., French A.R., Greco S., Yokoyama W.M. In vivo developmental stages in murine natural killer cell maturation. Nat Immunol 2002, 3:523-528.
37. Kumar V., McNerney M.E. A new self: MHC-class-I-independent natural-killer-cell self-tolerance. Nat Rev Immunol 2005, 5:363-374.
38. Kung S.K., Su R.C., Shannon J., Miller R.G. The NKR-P1B gene product is an inhibitory receptor on SJL/J NK cells. J Immunol 1999, 162:5876-5887.
39. Lanier L.L., Spits H., Phillips J.H. The developmental relationship between NK cells and T cells. Immunol Today 1992, 13:392-395.
40. Lanier L.L., Chang C., Phillips J.H. Human NKR-P1A. A disulfide-linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes. J Immunol 1994, 153:2417-2428.
41. Leclercq G., Debacker V., de Smedt M., Plum J. Differential effects of interleukin-15 and interleukin-2 on differentiation of bipotential T/natural killer progenitor cells. J Exp Med 1996, 184:325-336.
42. Lee K.M., McNerney M.E., Stepp S.E., Mathew P.A., Schatzle J.D., Bennett M., Kumar V. 2B4 acts as a non-major histocompatibility complex binding inhibitory receptor on mouse natural killer cells. J Exp Med 2004, 199:1245-1254.
43. Li J., Rabinovich B.A., Hurren R., Cosman D., Miller R.G. Survival versus neglect: redefining thymocyte subsets based on expression of NKG2D ligand(s) and I. Eur J Immunol 2005, 35:439-448.
44. Lian R.H., Chin R.K., Nemeth H.E., Libby S.L., Fu Y.X., Kumar V. A role for lymphotoxin in the acquisition of Ly49 receptors during NK cell development. Eur J Immunol 2004, 34:2699-2707.
45. Liu J., Morris M.A., Nguyen P., George T.C., Koulich E., Lai W.C., Schatzle J.D., Kumar V., Bennett M. Ly49I NK cell receptor transgene inhibition of rejection of H2b mouse bone marrow transplants. J Immunol 2000, 164:1793-1799.
46. Luci C., Reynders A., Ivanov II., Cognet C., Chiche L., Chasson L., Hardwigsen J., Anguiano E., Banchereau J., Chaussabel D., Dalod M., Littman D.R., Vivier E., Tomasello E. Influence of the transcription factor RORgammat on the development of NKp46(+) cell populations in gut and skin. Nat Immunol 2009, 10:75-82.
47. Mebius R.E. Organogenesis of lymphoid tissues. Nat Rev Immunol 2003, 3:292-303.
48. Mesci A., Ljutic B., Makrigiannis A.P., Carlyle J.R. NKR-P1 biology: from prototype to missing self. Immunol Res 2006, 35:13-26.
49. Michie A.M., Carlyle J.R., Schmitt T.M., Ljutic B., Cho S.K., Fong Q., Zúñiga-Pflücker J.C. Clonal characterization of a bipotent T cell and NK cell progenitor in the mouse fetal thymus. J Immunol 2000, 164:1730-1733.
50. Michie A.M., Carlyle J.R., Zúñiga-Pflücker J.C. Early intrathymic precursor cells acquire a CD4(low) phenotype. J Immunol 1998, 160:1735-1741.
51. Moingeon P., Rodewald H.R., McConkey D., Mildonian A., Awad K., Reinherz E.L. Generation of natural killer cells from both Fc gamma RII/III+ and Fc gamma RII/III- murine fetal liver progenitors. Blood 1993, 82:1453-1462.
52. Mortier E., Woo T., Advincula R., Gozalo S., Ma A. IL-15R alpha chaperones IL-15 to stable dendritic cell membrane complexes that activate NK cells via trans presentation. J Exp Med 2008, 205:1213-1225.
53. Ogasawara K., Hida S., Azimi N., Tagaya Y., Sato T., Yokochi-Fukuda T., Waldmann T.A., Taniguchi T., Taki S. Requirement for IRF-1 in the microenvironment supporting development of natural killer cells. Nature 1998, 391:700-703.
54. Ohteki T., Yoshida H., Matsuyama T., Duncan G.S., Mak T.W., Ohashi P.S. The transcription factor interferon regulatory factor 1 (IRF-1) is important during the maturation of natural killer 1.1+ T cell receptor-alpha/beta+ (NK1+ T) cells, natural killer cells, and intestinal intraepithelial T cells. J Exp Med 1998, 187:967-972.
55. Petrie H.T., Zúñiga-Pflücker J.C. Zoned out: functional mapping of stromal signalling microenvironments in the thymus. Annu Rev Immunol 2007, 25:649-679.
56. Phillips J.H., Hori T., Nagler A., Bhat N., Spits H., Lanier L.L. Ontogeny of human natural killer (NK) cells: fetal NK cells mediate cytolytic function and express cytoplasmic CD3 epsilon, delta proteins. J Exp Med 1992, 175:1055-1066.
57. Pilbeam K., Basse P., Brossay L., Vujanovic N., Gerstein R., Vallejo A.N., Borghesi L. The ontogeny and fate of NK cells marked by permanent DNA rearrangements. J Immunol 2008, 180:1432-1441.
58. Raulet D.H. Development and tolerance of natural killer cells. Curr Opin Immunol 1999, 11:129-134.
59. Raulet D.H., Vance R.E. Self-tolerance of natural killer cells. Nat Rev Immunol 2006, 6:520-531.
60. Raulet D.H., Held W., Correa I., Dorfman J.R., Wu M.F., Corral L. Specificity, tolerance and developmental regulation of natural killer cells defined by expression of class I-specific Ly49 receptors. Immunol Rev 1997, 155:41-52.
61. Reya T., Yang-Snyder J.A., Rothenberg E.V., Carding S.R. Regulated expression and function of CD122 (interleukin-2/interleukin-15R-beta) during lymphoid development. Blood 1996, 87:190-201.
62. Rodewald H.R., Moingeon P., Lucich J.L., Dosiou C., Lopez P., Reinherz E.L. A population of early fetal thymocytes expressing Fc gamma RII/III contains precursors of T lymphocytes and natural killer cells. Cell 1992, 69:139-150.
63. Rodewald H.R., Kretzschmar K., Takeda S., Hohl C., Dessing M. Identification of pro-thymocytes in murine fetal blood: T lineage commitment can precede thymus colonization. Embo J 1994, 13:4229-4240.
64. Rodewald H.R., Ogawa M., Haller C., Waskow C., DiSanto J.P. Pro-thymocyte expansion by c-kit and the common cytokine receptor gamma chain is essential for repertoire formation. Immunity 1997, 6:265-272.
65. Rolink A.G., Balciunaite G., Demoliere C., Ceredig R. The potential involvement of Notch signaling in NK cell development. Immunol Lett 2006, 107:50-57.
66. Rosen D.B., Bettadapura J., AlsharifiM., Mathew P.A., Warren H.S., Lanier L.L. Cutting edge: lectin-like transcript-1 is a ligand for the inhibitory human NKR-P1A receptor. J Immunol 2005, 175:7796-7799.
67. Rosen D.B., Cao W., Avery D.T., Tangye S.G., Liu Y.J., Houchins J.P., Lanier L.L. Functional consequences of interactions between human NKR-P1A and its ligand LLT1 expressed on activated dendritic cells and B cells. J Immunol 2008, 180:6508-6517.
68. Rosmaraki E.E., Douagi I., Roth C., Colucci F., Cumano A., Di Santo J.P. Identification of committed NK cell progenitors in adult murine bone marrow. Eur J Immunol 2001, 31:1900-1909.
69. Ryan J.C., Turck J., Niemi E.C., Yokoyama W.M., Seaman W.E. Molecular cloning of the NK1.1 antigen, a member of the NKR-P1 family of natural killer cell activation molecules. J Immunol 1992, 149:1631-1635.
70. Saito H., Kanamori Y., Takemori T., Nariuchi H., Kubota E., Takahashi-Iwanaga H., Iwanaga T., Ishikawa H. Generation of intestinal T cells from progenitors residing in gut cryptopatches. Science 1998, 280:275-278.
71. Sanchez M.J., Spits H., Lanier L.L., Phillips J.H. Human natural killer cell committed thymocytes and their relation to the T cell lineage. J Exp Med 1993, 178:1857-1866.
72. Sanchez M.J., Muench M.O., Roncarolo M.G., Lanier L.L., Phillips J.H. Identification of a common T/natural killer cell progenitor in human fetal thymus. J Exp Med 1994, 180:569-576.
73. Sanos S.L., Bui V.L., Mortha A., Oberle K., Heners C., Johner C., Diefenbach A. RORgammat and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46(+) cells. Nat Immunol 2009, 10:83-91.
74. Satoh-Takayama, N., Vosshenrich, C.A., Lesjean-Pottier, S., Sawa, S., Lochner, M., Rattis, F., Mention, J.J., Thiam, K., Cerf-Bensussan, N., Mandelboim, O., Eberl, G. and Di Santo, J.P. (2008). Microbial flora drives interleukin 22 production in intestinal NKp46(+) cells that provide innate mucosal immune defense. Immunity.
75. Schmitt T.M., Zúñiga-Pflücker J.C. Induction of T cell development from hematopoietic progenitor cells by delta-like-1 in vitro. Immunity 2002, 17:749-756.
76. Schmitt T.M., Ciofani M., Petrie H.T., Zúñiga-Pflücker J.C. Maintenance of T cell specification and differentiation requires recurrent notch receptor-ligand interactions. J Exp Med 2004, 200:469-479.
77. Schott E., Bonasio R., Ploegh H.L. Elimination in vivo of developing T cells by natural killer cells. J Exp Med 2003, 198:1213-1224.
78. Shen H.Q., Lu M., Ikawa T., Masuda K., Ohmura K., Minato N., Katsura Y., Kawamoto H. T/NK bipotent progenitors in the thymus retain the potential to generate dendritic cells. J Immunol 2003, 171:3401-3406.
79. Spits H., Blom B., Jaleco A.C., Weijer K., Verschuren M.C., van Dongen J.J., Heemskerk M.H., Res P.C. Early stages in the development of human T, natural killer and thymic dendritic cells. Immunol Rev 1998, 165:75-86.
80. Stevenaert F., Van Beneden K., De Colvenaer V., Franki A.S., Debacker V., Boterberg T., Deforce D., Pfeffer K., Plum J., Elewaut D., Leclercq G. Ly49 and CD94/NKG2 receptor acquisition by NK cells does not require lymphotoxin-beta receptor expression. Blood 2005, 106:956-962.
81. Stewart C.A., Walzer T., Robbins S.H., Malissen B., Vivier E., Prinz I. Germ-line and rearranged Tcrd transcription distinguish bona fide NK cells and NK-like gammadelta T cells. Eur J Immunol 2007, 37:1442-1452.
82. Van Beneden K., De Creus A., Debacker V., De Boever J., Plum J., Leclercq G. Murine fetal natural killer cells are functionally and structurally distinct from adult natural killer cells. J Leukoc Biol 1999, 66:625-633.
83. Van Beneden K., Stevenaert F., De Creus A., Debacker V., De Boever J., Plum J., Leclercq G. Expression of Ly49E and CD94/NKG2 on fetal and adult NK cells. J Immunol 2001, 166:4302-4311.
84. Van Den Broeck T., Stevenaert F., Taveirne S., Debacker V., Vangestel C., Vandekerckhove B., Taghon T., Matthys P., Plum J., Held W., Dewerchin M., Yokoyama W.M., Leclercq G. Ly49E-dependent inhibition of natural killer cells by urokinase plasminogen activator. Blood 2008, 112:5046-5051.
85. Veinotte L.L., Greenwood C.P., Mohammadi N., Parachoniak C.A., Takei F. Expression of rearranged TCRgamma genes in natural killer cells suggests a minor thymus-dependent pathway of lineage commitment. Blood 2006, 107:2673-2679.
86. Veinotte L.L., Halim T.Y., Takei F. Unique subset of natural killer cells develops from progenitors in lymph node. Blood 2008, 111:4201-4208.
87. Vosshenrich C.A., Garcia-Ojeda M.E., Samson-Villeger S.I., Pasqualetto V., Enault L., Richard-Le Goff O., Corcuff E., Guy-Grand D., Rocha B., Cumano A., Rogge L., Ezine S., Di Santo J.P. A thymic pathway of mouse natural killer cell development characterized by expression of GATA-3 and CD127. Nat Immunol 2006, 7:1217-1224.
88. Wilson A., Petrie H.T., Scollay R., Shortman K. The acquisition of CD4 and CD8 during the differentiation of early thymocytes in short-term culture. Int Immunol 1989, 1:605-612.
89. Yadi H., Burke S., Madeja Z., Hemberger M., Moffett A., Colucci F. Unique receptor repertoire in mouse uterine NK cells. J Immunol 2008, 181:6140-6147.
90. Yokoyama W.M., Plougastel B.F. Immune functions encoded by the natural killer gene complex. Nat Rev Immunol 2003, 3:304-316.
91. Yoshida H., Kawamoto H., Santee S.M., Hashi H., Honda K., Nishikawa S., Ware C.F., Katsura Y., Nishikawa S.I. Expression of alpha(4)beta(7) integrin defines a distinct pathway of lymphoid progenitors committed to T cells, fetal intestinal lymphotoxin producer, NK, and dendritic cells. J Immunol 2001, 167:2511-2521.
92. Yoshida H., Naito A., Inoue J., Satoh M., Santee-Cooper S.M., Ware C.F., Togawa A., Nishikawa S., Nishikawa S. Different cytokines induce surface lymphotoxin-alphabeta on IL-7 receptor-alpha cells that differentially engender lymph nodes and Peyer's patches. Immunity 2002, 17:823-833.
93. Yoshida T., Ng S.Y., Zúñiga-Pflücker J.C., Georgopoulos K. Early hematopoietic lineage restrictions directed by Ikaros. Nat Immunol 2006, 7:382-391.
94. Zenewicz L.A., Yancopoulos G.D., Valenzuela D.M., Murphy A.J., Stevens S., Flavell R.A. Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity 2008, 29:947-957.